Six hundred and fifty New Zealand children from 2-12 years of age were vaccinated three times with 2 mcg intramuscular (IM) doses of Merck Sharp and Dohme plasma-derived hepatitis B vaccine (H-B-Vax), at 0, 1, and 6 months, and tested 2-3 months later for antibody to hepatitis B surface antigen (ant
Immunogenicity of low doses of hepatitis B vaccine in normal children
โ Scribed by Nicolas Matsaniotis; Christos Kattamis; Elizabeth Dionyssopouolou; Sophia Laskari
- Book ID
- 119528898
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 224 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The immunogenic effect of hepatitis B vaccine was evaluated in 183 seronegative infants from Senegal. Seventy-two seronegative infants received two 5-micrograms doses of vaccine at a two-month interval and 111 seronegative infants received three 5-micrograms doses at one-month intervals. All the chi
The immunogenicity of a 5-micrograms dose of vaccine (H-B-Vax, MSD) was evaluated in 50 young adults (17-19 years). Results were compared to our previous studies using similarly prepared vaccines using 20 micrograms and 10 micrograms per dose with the same trial protocol in a comparable population.